Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Product sales $ 589 $ 1,192
Operating cost and expense        
Cost of product sales 3,140 5,671
Research and development cost 1,367 1,887 6,538 4,080
General and administrative expense 1,925 1,434 4,897 4,245
Impairment charge 2,411
Total operating expense 6,432 3,321 19,517 8,325
Loss from operations (5,843) (3,321) (18,325) (8,325)
Other income and expenses        
Interest expense (454) (203) (1,250) (318)
Interest and other income 7 7 28 22
Total other income (expense), net (447) (196) (1,222) (296)
Loss before income tax expense (6,290) (3,517) (19,547) (8,621)
Income tax expense (2) (1)
Net loss $ (6,290) $ (3,517) $ (19,549) $ (8,622)
Weighted average shares outstanding, basic and diluted (in shares) 20,265,020 15,574,620 19,732,372 14,818,484
Basic and diluted net loss per share (in dollars per share) $ (0.31) $ (0.23) $ (0.99) $ (0.58)